{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:59:47Z","timestamp":1788184787198,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":275,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62273329"],"award-info":[{"award-number":["62273329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-17-23"],"award-info":[{"award-number":["320.6750.2024-17-23"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2025-6-93"],"award-info":[{"award-number":["320.6750.2025-6-93"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-18-41"],"award-info":[{"award-number":["320.6750.2022-18-41"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-09-54"],"award-info":[{"award-number":["320.6750.2022-09-54"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.101015","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:16:46Z","timestamp":1759558606000},"page":"101015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A retrospective analysis of the efficacy and safety of immune combination therapy in driver gene-negative non-small cell lung cancer with brain metastases"],"prefix":"10.1016","volume":"45","author":[{"given":"Kuo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaishuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2025.101015_bib0001","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.ctarc.2025.101015_bib0002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1200\/JOP.19.00357","article-title":"Management of brain metastases in non-small-cell lung cancer","volume":"15","author":"Ernani","year":"2019","journal-title":"J. Oncol. Pract."},{"issue":"5","key":"10.1016\/j.ctarc.2025.101015_bib0003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101015_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3171\/2015.6.JNS142763","article-title":"Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?","volume":"125","author":"Colaco","year":"2016","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.ctarc.2025.101015_bib0005","first-page":"5","article-title":"Brain metastasis","author":"Boire","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"22","key":"10.1016\/j.ctarc.2025.101015_bib0006","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ctarc.2025.101015_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577159","article-title":"Response of Pembrolizumab alone for non-small cell lung cancer with brain metastasis: a case report and literature review","volume":"10","author":"Marvin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2025.101015_bib0008","first-page":"1","article-title":"Immunotherapy for advanced non\u2013small cell lung cancer: a decade of progress","volume":"41","author":"Shields","year":"2021","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"7","key":"10.1016\/j.ctarc.2025.101015_bib0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101015_bib0010","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jtho.2019.02.009","article-title":"Outcome of patients with non\u2013small cell lung cancer and brain metastases treated with checkpoint inhibitors","volume":"14","author":"Hendriks","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2025.101015_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1110440","article-title":"The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases","volume":"13","author":"Billena","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2025.101015_bib0012","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1158\/1078-0432.CCR-06-2070","article-title":"Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function","volume":"13","author":"Fecci","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101015_bib0013","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1057388","article-title":"Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases","volume":"5","author":"Berghoff","year":"2016","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.ctarc.2025.101015_bib0014","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","article-title":"Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas","volume":"86","author":"Zeng","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2025.101015_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.787080","article-title":"Immunotherapy in NSCLC patients with brain and leptomeningeal metastases","volume":"12","author":"Pierret","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2025.101015_bib0016","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/cancers17152434","article-title":"The landscape and management of brain parenchymal and leptomeningeal metastases in EGFR mutated non-small cell lung cancer","volume":"17","author":"Hyak","year":"2025","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.ctarc.2025.101015_bib0017","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3390\/jcm13185489","article-title":"Efficacy and safety of Amivantamab in advanced or metastatic EGFR-mutant non-small cell lung cancer: a systematic review","volume":"13","author":"Papassotiriou","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ctarc.2025.101015_bib0018","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2019.05.019","article-title":"Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors","volume":"116","author":"Hendriks","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ctarc.2025.101015_bib0019","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2017.02.022","article-title":"Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient","volume":"108","author":"Gion","year":"2017","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2025.101015_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11060-011-0664-8","article-title":"Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment","volume":"106","author":"Kim","year":"2012","journal-title":"J. Neurooncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101015_bib0021","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11864-020-00759-3","article-title":"Leptomeningeal metastases in non-small cell lung cancer: optimal systemic management in NSCLC with and without driver mutations","volume":"21","author":"Alexander","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101015_bib0022","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13014-019-1376-z","article-title":"Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis","volume":"14","author":"Yan","year":"2019","journal-title":"Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.ctarc.2025.101015_bib0023","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2025.101015_bib0024","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3389\/fonc.2019.01224","article-title":"Radiotherapy in leptomeningeal disease: a systematic review of randomized and non-randomized trials","volume":"9","author":"Buszek","year":"2019","journal-title":"Front. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:22:24Z","timestamp":1773163344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"alternative-id":["S2468294225001510"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101015","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective analysis of the efficacy and safety of immune combination therapy in driver gene-negative non-small cell lung cancer with brain metastases","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101015"}}